Electrochemical Behavior and Differential Pulse Polarographic Determination of Rifampicin in the Pharmaceutical Preparations

Archives of Pharmacal Research

Volumn 24, Issue 2, 2001, Pages 100-104

  Hahn, Younghee ^a   Shin, Sunmi ^a  

^a Sangmyung University   (South Korea)

Author keywords

Cyclic voltammetry; Differential pulse polarography; Rifampicin

Indexed keywords

ELECTROLYTE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; ELECTROCHEMISTRY; MICROCAPSULE; PH; POLAROGRAPHY;

ANTIBIOTICS, ANTITUBERCULAR; CAPSULES; ELECTROCHEMISTRY; ELECTROLYTES; HYDROGEN-ION CONCENTRATION; POLAROGRAPHY; RIFAMPIN;

EID: 0035316054     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976475     Document Type: Article

References (12)

1. Argekar, A. P., Kunjir, S. S. and Purandare, K. S., Simultaneous determination of rifampicin, isoniazid and pyrazinamid by high performance thin layer chromatography, J. Pharm. Biomed. Anal., 14, 1645-1650 (1996).
2. Blaedel, W. J. and Hahn, Y., Investigation of diazepam by pulsed rotation voltammetry, Arch. Pharm. Res., 2(2), 111-114 (1979).
3. British Pharmacopoeia Commission, British Pharmacopoeia, The Stationery Office, London, 1346-1347, 2000.
4. European Pharmacopoeia Commission, European Pharmacopeia, Council of Europe, Strasbourg, 1446-1447 (1997).
5. Galal, S. M., Blaih, S. M., and Abdel-Hamid, M. E., Comparative spectrophotometric analysis of rifampicin by chelate formation and charge-transfer complexation, Anal. Lett., 25(4), 725-743 (1992).
6. Gallo, G. G., Chiesa, L., and Sensi, P., Rifamycin XXIII. The polarographic behavior of rifamycin B, rifamycin O, rifamycin S, and rifamycin SV, Anal. Chem., 34(3), 423-426 (1962).
7. Hahn, Y. and Son, E., Electrochemical behavior and differential pulse polarographic determination of piperacillin sodium, Arch. Pharm. Res., 23(2), 197-201 (2000).
8. Jindal, K. C., Chaudhary, R. S., Gangwal, S. S., Singla, A. K., and Khanna, S., High-performance thin-layer chromatographic method for monitoring degradation products of rifampicin in drug excipient interaction studies, J. Chromato. A, 685, 195-199 (1994).
9. Korea Food and Drug Administration, The minimum Requirements for Antibiotic Products of Korea, Yakup Shinmoon Co., Korea, 55-58 (2000).
10. Lund, H., Reduction of azomethine compounds, In Lund, H. and Baizer, M. M. (Eds.) Organic electrochemistry, an introduction and a guide, 3rd ed. Marcel Dekker, New York, 465-466 (1991).
11. United States Pharmacopeial Convention, U. S. Pharmacopeia & National Formulary, National Publishing, Philadelphia, PA, 1484-1487 (2000).
12. Walash, M. I., Belal, F., Metwally, M. E., and Hefnawy, M. Mt., Spectrophotometric determination of rifampicin in the presence of its degradation products in pharmaceutical preparations, Anal. Lett., 26(9), 1905-1917 (1993).